BBGBloomberg·2hBusiness
score-0.35
India's Generic Semaglutide Launch Sparks Lasting Growth in Obesity and Diabetes Drug Market Despite Post-Surge Stabilization
Original
India Fat-Loss Drug Sales Slow After Early Spike From Generics
“Headline uses softly negative framing ('losing steam,' 'slow') to describe market dynamics without catastrophizing or urgent alarm language.”